Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for pharmaceutical
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Aleksandra Czubek on Thursday, November 23, 2023 Rating: 5
Novartis v. Teva: Patent rivalries meet again, this time on a non-negligible injunction. Novartis v. Teva: Patent rivalries meet again, this time on a non-negligible injunction. Reviewed by Frantzeska Papadopoulou on Friday, June 29, 2018 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.